Evrofarma SA
ATHEX:EVROF
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.92
1.92
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one EVROF stock under the Base Case scenario is 1.99 EUR. Compared to the current market price of 1.41 EUR, Evrofarma SA is Undervalued by 29%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Evrofarma SA
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for EVROF cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Evrofarma SA
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Evrofarma SA
Balance Sheet Decomposition
Evrofarma SA
Current Assets | 19m |
Cash & Short-Term Investments | 470k |
Receivables | 9.7m |
Other Current Assets | 8.9m |
Non-Current Assets | 30.5m |
Long-Term Investments | 622k |
PP&E | 29.9m |
Intangibles | 33k |
Other Non-Current Assets | 25k |
Current Liabilities | 13.8m |
Accounts Payable | 6.8m |
Short-Term Debt | 3.3m |
Other Current Liabilities | 3.7m |
Non-Current Liabilities | 18.1m |
Long-Term Debt | 11m |
Other Non-Current Liabilities | 7.1m |
Earnings Waterfall
Evrofarma SA
Revenue
|
46.8m
EUR
|
Cost of Revenue
|
-31.1m
EUR
|
Gross Profit
|
15.7m
EUR
|
Operating Expenses
|
-11.6m
EUR
|
Operating Income
|
4.1m
EUR
|
Other Expenses
|
-1.9m
EUR
|
Net Income
|
2.2m
EUR
|
Free Cash Flow Analysis
Evrofarma SA
EUR | |
Free Cash Flow | EUR |
EVROF Profitability Score
Profitability Due Diligence
Evrofarma SA's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Score
Evrofarma SA's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
EVROF Solvency Score
Solvency Due Diligence
Evrofarma SA's solvency score is 36/100. The higher the solvency score, the more solvent the company is.
Score
Evrofarma SA's solvency score is 36/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
EVROF Price Targets Summary
Evrofarma SA
Dividends
Current shareholder yield for EVROF is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Evrofarma SA engages in the production of milk and dairy products. The firm offers five ranges of products: Milk, including fresh whole, semi-skimmed and skimmed milk, highly pasteurized milk and chocolate flavored milk; the traditional Ariani Milk Drink, available also with added flavors; Yogurt, including traditional, cow-milk and strained yogurt; Milk Cream, as well as Cheese, such as goat, feta and organic feta cheese and anthotiro. The company also supplies the yellow cheeses of Doiranis brand, including traditional kasseri and semi-hard cheeses. The Company’s milk supplies come from various farmers and associates in Macedonia and Thrace. Its production facilities cover 10,000 square meters and it has four distribution centers in Northern Greece, as well as a fleet of privately owned trucks that distribute its products in more than 3,000 points of sale locations. Evrofarma SA has a wholly owned subsidiary, Campus SA, which deals mainly with milk production.
Contact
IPO
Employees
Officers
The intrinsic value of one EVROF stock under the Base Case scenario is 1.99 EUR.
Compared to the current market price of 1.41 EUR, Evrofarma SA is Undervalued by 29%.